Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Sep 15 2022

Full Issue

Research Roundup: Covid; Dementia; Pain Management

Each week, KHN compiles a selection of recently released health policy studies and briefs.

CIDRAP: Study Finds MRSA Bacteremia Rate Much Higher In NYC COVID-19 Patients

The rate of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia was five times higher among COVID-19 patients than non-COVID patients at 11 New York City hospitals during the pandemic, researchers reported last week in Infection Control & Hospital Epidemiology. (9/12)

CIDRAP: COVID-19 Vaccines Not Tied To Lower Fertility In Men Or Women

A systematic review and meta-analysis today in Vaccine finds no link between COVID-19 vaccines and infertility in men or women. ... Fertility markers in men and women were unchanged before and after COVID-19 vaccination of any type (ie, Pfizer/BioNTech, Moderna, or Sputnik V). The latter is not authorized for use in the United States. (9/12)

CIDRAP: COVID Boosters Safe And Well Tolerated In Pregnant And Lactating Women

COVID vaccine boosters or third doses after an initial two-dose series are well tolerated in pregnant and lactating women, according to a large cohort study published yesterday in JAMA Network Open. (9/9)

CIDRAP: Study Finds Omicron Hospital Risk 10 Times Higher In Unvaccinated

After the emergence of the Omicron variant, the rate of COVID-19 hospitalizations in the United States was 10.5 times higher in unvaccinated adults and 2.5 times higher in those who were vaccinated but received no booster than in booster recipients, according to a new study. (Van Beusekom, 9/9)

CIDRAP: Most COVID Survivors Had Cardiac Involvement Nearly 1 Year Later

A study of 346 previously healthy COVID-19 survivors finds that 73% had cardiac signs and symptoms more than 3 months after infection, and 57% still had them at nearly 1 year. In the study, published yesterday in Nature Medicine, a team led by University Hospital Frankfurt researchers in Germany measured blood biomarkers of heart injury and dysfunction and performed magnetic resonance imaging (MRI) on 346 COVID-19 survivors who had no previous heart disease or notable chronic conditions at a median of 109 and 329 days. (9/6)

Also —

CIDRAP: High Rate Of Antibiotic Use Found In People With Dementia

A study of Veterans Health Administration data found that antibiotic prescribing was prevalent among a national cohort of persons living with dementia (PLWD), and inappropriate use appeared high, researchers reported late last week in Open Forum Infectious Diseases. (9/7)

ScienceDaily: Researchers Develop Bioresorbable, Implantable Device To Block Pain Signals From Peripheral Nerves 

Researchers test the efficacy of a soft, bioresorbable, implantable device to block pain signals from sciatic nerves of rat models. (Pusan National University, 9/6)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF